Evidence map›Paper›PMID 37460827›Full record

ArticleDiabetologia2023

Reversal of dual epigenetic repression of non-canonical Wnt-5a normalises diabetic corneal epithelial wound healing and stem cells.

Ruchi Shah, Tanya M Spektor, Daniel J Weisenberger, Hui Ding, Rameshwar Patil, Cynthia Amador, Xue-Ying Song, Steven T Chun, Jake Inzalaco, Sue Turjman and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Role of epigenetic regulation in diminished ovarian reserve.Journal of assisted reproduction and genetics · 2025
    Review
  14. Article
  15. Role of epigenetics in corneal health and disease.Progress in retinal and eye research · 2025
    Review
  16. Article
  17. Article
  18. Epigenetics-targeted drugs: current paradigms and future challenges.Signal transduction and targeted therapy · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 4 countries.

Ruchi ShahBiomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Ruchi.Shah@cshs.org.ORCID http://orcid.org/0000-0002-9533-1747
Tanya M SpektorBoard of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Daniel J WeisenbergerKeck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Hui DingNeurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Rameshwar PatilNeurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Cynthia AmadorBiomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Xue-Ying SongApplied Genomics, Computation, and Translational Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Steven T ChunBoard of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Jake InzalacoBoard of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sue TurjmanBiomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sean GhiamBoard of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Jiho Jeong-KimBoard of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sasha TolstoffBoard of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sabina V YampolskyBoard of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Onkar B SawantCenter for Vision and Eye Banking Research, Eversight, Cleveland, OH, USA.
Yaron S RabinowitzBoard of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Ezra MaguenAmerican Eye Institute, Los Angeles, CA, USA.
Pedram HamrahCornea Service, New England Eye Center, Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, MA, USA.
Clive N SvendsenBiomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Mehrnoosh SaghizadehBiomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Julia Y LjubimovaNeurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Andrei A KramerovBiomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Alexander V LjubimovBiomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. ljubimov@cshs.org.ORCID http://orcid.org/0000-0003-2398-5319
Cedars-Sinai Medical Center · USCalifornia Institute of Technology · USTufts University · USUniversity of Southern California · US

Funding

Mechanisms of Epithelial Alterations in Diabetic CorneaR01EY013431 · NEI · CEDARS-SINAI MEDICAL CENTER · PI Alexander V Ljubimov · 2001 to 2026
$11.3M
The Role of MicroRNAs in Normal and Diseased Corneal Epithelial HomeostasisR01EY025377 · NEI · CEDARS-SINAI MEDICAL CENTER · PI Mehrnoosh Saghizadeh Ghiam · 2015 to 2026
$4.3M
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumorsR01CA206220 · NCI · CEDARS-SINAI MEDICAL CENTER · PI LJUBIMOVA, JULIA Y · 2016 to 2020
$2.8M
Wnt5a, a New Diabetic Corneal Marker Related to Wound HealingR01EY031377 · NEI · CEDARS-SINAI MEDICAL CENTER · PI LJUBIMOV, ALEXANDER V · 2020 to 2024
$2.1M
NCI NIH HHS R01 CA206220NEI NIH HHS R01 EY013431NEI NIH HHS R01 EY025377NEI NIH HHS R01 EY031377
6 · The paper itself

Abstract

aims/hypothesisDiabetes is associated with epigenetic modifications including DNA methylation and miRNA changes. Diabetic complications in the cornea can cause persistent epithelial defects and impaired wound healing due to limbal epithelial stem cell (LESC) dysfunction. In this study, we aimed to uncover epigenetic alterations in diabetic vs non-diabetic human limbal epithelial cells (LEC) enriched in LESC and identify new diabetic markers that can be targeted for therapy to normalise corneal epithelial wound healing and stem cell expression.

methodsHuman LEC were isolated, or organ-cultured corneas were obtained, from autopsy eyes from non-diabetic (59.87±20.89 years) and diabetic (71.93±9.29 years) donors. The groups were not statistically different in age. DNA was extracted from LEC for methylation analysis using Illumina Infinium 850K MethylationEPIC BeadChip and protein was extracted for Wnt phospho array analysis. Wound healing was studied using a scratch assay in LEC or 1-heptanol wounds in organ-cultured corneas. Organ-cultured corneas and LEC were transfected with WNT5A siRNA, miR-203a mimic or miR-203a inhibitor or were treated with recombinant Wnt-5a (200 ng/ml), DNA methylation inhibitor zebularine (1-20 µmol/l) or biodegradable nanobioconjugates (NBCs) based on polymalic acid scaffold containing antisense oligonucleotide (AON) to miR-203a or a control scrambled AON (15-20 µmol/l).

resultsThere was significant differential DNA methylation between diabetic and non-diabetic LEC. WNT5A promoter was hypermethylated in diabetic LEC accompanied with markedly decreased Wnt-5a protein. Treatment of diabetic LEC and organ-cultured corneas with exogenous Wnt-5a accelerated wound healing by 1.4-fold (p<0.05) and 37% (p<0.05), respectively, and increased LESC and diabetic marker expression. Wnt-5a treatment in diabetic LEC increased the phosphorylation of members of the Ca CONCLUSIONS/

interpretationWe provide the first account of epigenetic changes in diabetic corneas including dual inhibition of WNT5A by DNA methylation and miRNA action. Overall, Wnt-5a is a new corneal epithelial wound healing stimulator that can be targeted to improve wound healing and stem cells in the diabetic cornea. DATA AVAILABILITY: The DNA methylation dataset is available from the public GEO repository under accession no. GSE229328 ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE229328 ).

Indexed as

Diabetes MellitusMicroRNAsEpigenetic RepressionEpithelial CellsHumansRNA, Small InterferingStem CellsWnt-5a ProteinWound HealingMicroRNAsRNA, Small InterferingWnt-5a ProteinCorneal stem cellsDiabetic keratopathyDNA methylationEpigeneticsGene therapymiRNAWnt-5aWnt signalling

Identifiers

PMID37460827
PMCPMC10474199
OpenAlexW4384498129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.